Trending Now
Actuate Therapeutics Recently Issued an Update on Its Phase Two Study...
Actuate Therapeutics recently executed a partnership with the University of Kansas Cancer Center to research and develop the elraglusib Drug. The partnership focuses on...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Tapping Recession-Proof Stocks to Fight the Bear (SNPS, KEGS, SAM, ABT,...
Fed Chair Jay Powell took a trip to Capitol Hill this week for his regular interrogation by Congress – no doubt a...
MAKE IT MODERN
LATEST REVIEWS
InflaRx N.V. (NASDAQ: IFRZX) Receives Corrected Advice Letter From The FDA...
InflaRx N.V. (NASDAQ: IFRZX) has announced that the US FDA has granted it a corrected advice letter related to the third phase program with...
MAKE IT MODERN
PERFORMANCE TRAINING
Janux Therapeutics Reports Breakthrough in Prostate Cancer Treatment with JANX007
In a significant development from San Diego, Janux Therapeutics, Inc. (NASDAQ: JANX) has released an update on its groundbreaking JANX007 clinical program,...
Aion Therapeutic Inc. (CNSX:AION) Confirms Management Appointment Amid Debentures Restructuring
Formerly known Osoyoos Cannabis Inc., Aion Therapeutic Inc. (CNSX:AION) researches, grows, and markets medical cannabis in Canada. The company has carried out a number...
Stocks to End the Opioid Epidemic (ECOR, PCRX, ENDV, NVCR)
Opioid drugs have done more damage over the last few years than Covid-19. But now, because of the pandemic, the opioid crisis has significantly...
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP, STZ, DEO, ABEV,...
The US Federal Reserve continued with its steep tightening agenda for monetary policy in the United States on Wednesday, raising the policy...
Galecto Inc (NASDAQ: GLTO) Enrolls Patients in GULLIVER-2 Study
Galecto Inc (NASDAQ: GLTO) has enrolled patients for the second and third parts of its Phase Ib/IIa GB1211, GULLIVER-2 study. The company...
MAKE IT MODERN
